A Critical Review of the Safety and Antiemetic Efficacy of Delta-9-Tetrahydrocannabinol (Q40126671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

review article

1 reference

title

A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Critical Review of the Safety and Antiemetic Efficacy of Delta-9-Tetrahydrocannabinol (English)

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

12 September 2023

0 references

0 references

D. M. Cocchetto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6271519

12 September 2023

L. F. Cook

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6271519

12 September 2023

A. E. Cato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6271519

12 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6271519

12 September 2023

publication date

1 November 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

http://journals.sagepub.com/doi/pdf/10.1177/106002808101501104

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Drug Intelligence & Clinical Pharmacy

12 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

867-875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

30 October 2019

cites work

11

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Pharmacology of orally administered Δ9-tetrahydrocannabinol

12 September 2023

12

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Tetrahydrocannabinol: From Pot to Prescription?

12 September 2023

14

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Pretreatment nausea in cancer chemotherapy: a conditioned response?

12 September 2023

15

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

12 September 2023

16

5

43

Edelstyn GA

1979

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Cancer Treatment Needs Better Antiemetics

12 September 2023

18

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.

12 September 2023

19

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

12 September 2023

22

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

12 September 2023

23

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo

12 September 2023

24

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine

12 September 2023

26

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Cannabis and cancer chemotherapy

12 September 2023

29

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

The influence of alcohol and marihuana on motor and mental performance

12 September 2023

31

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Marijuana: Dose-Response Effects on Pulse Rate, Subjective Estimates of Potency, Pleasantness, and Recognition Memory

12 September 2023

32

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Marijuana: dose effects on pulse rate, subjective estimates of intoxication, free recall and recognition memory

12 September 2023

33

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Dose-response analysis of the efJects of tetrahydrocannabinol in man

12 September 2023

34

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

12 September 2023

35

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

12 September 2023

41

48

121

Lipman AG.

1980

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy

12 September 2023

45

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Metoclopramide: a review of its pharmacological properties and clinical use

12 September 2023

47

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

12 September 2023

Cancer Treatment Reports

48

62

1106

Kahn T

1978

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Methylprednisolone as an antiemetic during cancer chemotherapy--a pilot study

12 September 2023

53

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Side effects of anti-emetics: results of a class experiment.

12 September 2023

54

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

Cancer Patients: Joints or THC?

12 September 2023

56

1 reference

https://api.crossref.org/works/10.1177/106002808101501104

12 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6271519%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference